ClinicalTrials.Veeva

Menu

A Study to Evaluate Endoscope-assisted, Minimally-invasive Cortical Access System for Chronic Subdural Evacuation

Mayo Clinic logo

Mayo Clinic

Status

Terminated

Conditions

Chronic Subdural Hematoma

Treatments

Device: Minimally Invasive Cortical Access System (MICAS)

Study type

Interventional

Funder types

Other

Identifiers

NCT04502745
20-005086

Details and patient eligibility

About

The purpose of this study is to evaluate a less-invasive alternative to the currently available method of removing aging blood in the subdural space.

Enrollment

6 patients

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must be 55 years of age or greater.
  • Have a clinically symptomatic chronic subdural hematoma greater than 1 cm in maximal thickness and be judged clinically to need subdural evacuation.

Exclusion criteria

  • Failure to obtain consent.
  • Vulnerable study population.
  • Any need for chronic anticoagulation.
  • Pregnancy (verified by pregnancy testing at screening or medical history of a hysterectomy, oophorectomy, or post-menopausal).Prior surgery for subdural hematoma.
  • Glasgow Coma Scale (GCS) less than 8.

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

6 participants in 1 patient group

Treatment Group
Experimental group
Description:
During clinically indicated surgery for subdural hematoma, the patient will undergo a single burr hole evacuation with the MICAS device with endoscopic assistance.
Treatment:
Device: Minimally Invasive Cortical Access System (MICAS)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems